Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) appears in 380 institutional 13F filings for the quarter ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Avoro Capital Advisors LLC | 31 Dec, 2025 | 3,615,000 | 1,782,000 | 97.22% | $2,105,159,100.00 |
| BAKER BROS. ADVISORS LP | 31 Dec, 2025 | 2,141,701 | 0 | 0.00% | $1,247,198,160.00 |
| RTW INVESTMENTS, LP | 31 Dec, 2025 | 1,993,687 | 0 | 0.00% | $1,161,003,688.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 1,808,894 | -3,160 | -0.17% | $1,053,391,331.00 |
| PAULSON & CO. INC. | 31 Dec, 2025 | 1,707,522 | -200,001 | -10.48% | $994,358,361.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 1,644,750 | 85,038 | 5.45% | $957,803,431.00 |
| Janus Henderson Group Plc | 31 Dec, 2025 | 1,584,843 | -257,847 | -13.99% | $918,203,904.00 |
| Goldman Sachs Group Inc | 31 Dec, 2025 | 611,678 | 225,578 | 58.42% | $356,204,568.00 |
| State Street Corp | 31 Dec, 2025 | 583,003 | -75,094 | -11.41% | $339,505,967.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Dec, 2025 | 461,402 | 56,947 | 14.08% | $268,692,841.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 451,743 | 5,510 | 1.23% | $263,113,834.00 |
| FMR LLC | 31 Dec, 2025 | 439,398 | 38,262 | 9.54% | $255,879,233.00 |
| Bank Of America Corp /De/ | 31 Dec, 2025 | 416,025 | -72,559 | -14.85% | $242,267,998.00 |
| Invesco Ltd. | 31 Dec, 2025 | 365,314 | 65,749 | 21.95% | $212,736,955.00 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 31 Dec, 2025 | 354,220 | -57,582 | -13.98% | $206,276,475.00 |
| Polar Capital Holdings Plc | 31 Dec, 2025 | 270,151 | 4,997 | 1.88% | $157,319,733.00 |
| ARMISTICE CAPITAL, LLC | 31 Dec, 2025 | 265,705 | 145,723 | 121.45% | $154,730,650.00 |
| Hood River Capital Management LLC | 31 Dec, 2025 | 247,560 | 4,752 | 1.96% | $144,164,090.00 |
| LORD, ABBETT & CO. LLC | 31 Dec, 2025 | 244,796 | 142,653 | 139.66% | $142,555.00 |
| ALKEON CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 240,000 | 120,000 | 100.00% | $139,761,600.00 |